Compile Data Set for Download or QSAR
Report error Found 143 Enz. Inhib. hit(s) with all data for entry = 6979
TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163169BDBM163169(US9062045, 8)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163201BDBM163201(US9062045, 40)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163213BDBM163213(US9062045, 53)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163224BDBM163224(US9062045, 67)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163174BDBM163174(US9062045, 13)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163205BDBM163205(US9062045, 44)
Affinity DataIC50: 1nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163215BDBM163215(US9062045, 55)
Affinity DataIC50: 1.30nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163183BDBM163183(US9062045, 24)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163199BDBM163199(US9062045, 38)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163217BDBM163217(US9062045, 57)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163164BDBM163164(US9062045, 3)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163180BDBM163180(US9062045, 21)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163212BDBM163212(US9062045, 52)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163198BDBM163198(US9062045, 37)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163234BDBM163234(US9062045, 78)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163204BDBM163204(US9062045, 43)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163189BDBM163189(US9062045, 30)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163175BDBM163175(US9062045, 14)
Affinity DataIC50: 2nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163168BDBM163168(US9062045, 7)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163171BDBM163171(US9062045, 10)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163226BDBM163226(US9062045, 69)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163227BDBM163227(US9062045, 70)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163177BDBM163177(US9062045, 17)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163209BDBM163209(US9062045, 49)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163245BDBM163245(US9062045, Reference Example No. 66)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163243BDBM163243(US9062045, Comparator No. 1 (JNJ-38877605))
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163186BDBM163186(US9062045, 27)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163244BDBM163244(US9062045, Reference Example No. 63)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163218BDBM163218(US9062045, 58)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163219BDBM163219(US9062045, 59)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163190BDBM163190(US9062045, 31)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163230BDBM163230(US9062045, 74)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163196BDBM163196(US9062045, 35B)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163197BDBM163197(US9062045, 36)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163176BDBM163176(US9062045, 15)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163172BDBM163172(US9062045, 11)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163203BDBM163203(US9062045, 42)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163173BDBM163173(US9062045, 12)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163184BDBM163184(US9062045, 25)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163210BDBM163210(US9062045, 50)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163211BDBM163211(US9062045, 51)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163192BDBM163192(US9062045, 33)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163194BDBM163194(US9062045, 35)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50396934BDBM50396934(CHEMBL2170804 | CHEMBL2001019 | US9062045, Compara...)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163188BDBM163188(US9062045, 29)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163220BDBM163220(US9062045, 60)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163221BDBM163221(US9062045, 61)
Affinity DataIC50: 4nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163246BDBM163246(US9062045, Reference Example No. 73)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163233BDBM163233(US9062045, 77)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 163195BDBM163195(US9062045, 35A)
Affinity DataIC50: 5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

Displayed 1 to 50 (of 143 total ) | Next | Last >>
Jump to: